HML Henderson Mrly.

 

TIDMHML 
 
RNS Number : 3782C 
Henderson Morley PLC 
12 November 2009 
 
12 November 2009 
 
HENDERSON MORLEY PLC 
("Henderson Morley" or the "Company") 
(AIM: HML) 
APPOINTMENT 
The Board of Henderson Morley plc, the Aim quoted biotechnology company, is 
pleased to announce the appointment of Professor Anant Sharma to the Company's 
Scientific Advisory Board. Professor Sharma is a consultant ophthalmic surgeon 
at the Moorfields Eye Hospital (Bedford), and is Visiting Professor at Cranfield 
University. 
With over 40 publications, predominantly in the field of corneal surgery and 
disease, Professor Sharma is a member of the Royal College of Ophthalmologists 
Research and Development Working Party and has been involved with a number of 
clinical development projects for many aspects of ocular disease. 
It is anticipated that Professor Sharma will play an active role in the 
continued development of the ophthalmic indications of ICVT and act as an 
advisor to the Company on aspects of ophthalmic clinical trials and product 
development. 
Commenting, Henderson Morley's Chairman Andrew Knight said "I am very pleased to 
welcome Professor Sharma as a member of the Scientific Advisory Board, his 
knowledge and experience has already proven to be very valuable to our planned 
continued development of the ICVT ophthalmic product." 
 
=- END-- 
 
Enquires 
HENDERSON MORLEY PLC  0121 442 4600 
Andrew Knight, Chairman 
BISHOPSGATECOMMUNICATIONS LTD0207 562 3350 
Maxine Barnes 
 Gemma O'Hara 
BREWIN DOLPHIN INVESTMENT BANKING0113 241 0126 
Neil Baldwin 
RIVINGTON STREET CORPORATE FINANCE0207 562 3380 
Monisha Varadan 
=- End -- 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 STRUASBRKKRAAAA 
 

Grafico Azioni Henderson Mrly. (LSE:HML)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Henderson Mrly. (LSE:HML)
Storico
Da Giu 2023 a Giu 2024